These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7792024)

  • 1. Hyperlipidaemia of the nephrotic syndrome--the search for a nephrotic factor.
    Joven J; Vilella E
    Nephrol Dial Transplant; 1995; 10(3):314-6. PubMed ID: 7792024
    [No Abstract]   [Full Text] [Related]  

  • 2. Correction of hyperlipidaemia in a nephrotic patient during an episode of anuria.
    Tornero F; Torralbo A; Portolés J; Barrientos A
    Nephrol Dial Transplant; 1993; 8(11):1307. PubMed ID: 8302479
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathogenesis of lipid abnormalities in patients with nephrotic syndrome/proteinuria: clinical implications.
    Warwick GL; Packard CJ
    Miner Electrolyte Metab; 1993; 19(3):115-26. PubMed ID: 8232098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid abnormalities in the nephrotic syndrome: the therapeutic role of statins.
    Wheeler DC
    J Nephrol; 2001; 14 Suppl 4():S70-5. PubMed ID: 11798150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lipids in nephrotic syndrome.
    Banerjee SK; Sarkar AK; Chugh KS; Bansal VK; Chhuttani PN
    J Assoc Physicians India; 1972 Sep; 20(9):651-8. PubMed ID: 4654886
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of serum and urinary proteins, enzymes and isoenzymes and serum lipids in nephrotic syndrome].
    Gavosto JJ; Fay OH; García CA; Arnolt RI
    Arch Fund Roux Ocefa; 1971; 5(1):73-9. PubMed ID: 5156285
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of fibre in the treatment of secondary hyperlipidaemia in nephrotic patients.
    Gentile MG; Ciceri R; Manna GM; Delle Fave A; Zanoni C; Raschioni E; Combi S; Maiocchi V; D'Amico G
    Eur J Clin Nutr; 1995 Oct; 49 Suppl 3():S239-41. PubMed ID: 8549536
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on hyperlipidemia in nephrotic syndrome].
    PEZOLD FA
    Klin Wochenschr; 1959 Feb; 37(3):132-40. PubMed ID: 13642720
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long-term (6 years) course of a congenital nephrotic syndrome treated by constant rate enteral nutrition].
    Vainsel M; Vertongen F; Mozin MJ; Gilbert L; Maurus R; Broyer M
    Ann Pediatr (Paris); 1986 Sep; 33(7):605-7. PubMed ID: 3096184
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of oral administration of epsilon-aminocaproic acid on serum lipids in patients with nephrotic syndrome].
    Markiewicz K; Walasek L
    Pol Tyg Lek; 1973 Jul; 28(29):1097-100. PubMed ID: 4728793
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lipid disturbances in the nephrotic syndrome].
    Chmielewski M; Zdrojewski Z; Rutkowski B
    Przegl Lek; 2003; 60(11):758-61. PubMed ID: 15058052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
    J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive study on platelet function, hemostasis, fibrinolysis, peripheral serotonergic system and serum lipids in nephrotic syndrome.
    Małyszko J; Małyszko JS; Pawlak D; Pawlak K; Rydzewski A; Myśliwiec M; Buczko W
    Pol J Pharmacol; 1996; 48(2):191-5. PubMed ID: 9112650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary concentrating capacity in patients with nephrotic syndrome.
    Date U; Kaushik RV; Ali U; Mehta KP
    Indian Pediatr; 1990 Oct; 27(10):1095-8. PubMed ID: 2090597
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum and urine electrolytes in the nephrotic syndrome in childhood].
    Reis SI; Mattos Junior A; Brooking C
    Bol Inst Pueric Martagao Gesteira; 1970; 26():15-9. PubMed ID: 5520330
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lipid metabolic disorders and lipid peroxidation in patients with the nephrotic syndrome].
    Shishkin AN; Kolmakova EV; Ashirova KV
    Urol Nefrol (Mosk); 1994; (3):39-41. PubMed ID: 8079411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On the lipid metabolism of the nephrotic syndrome (author's transl)].
    Senaga R
    Rinsho Byori; 1975 Oct; 23(10):782-6. PubMed ID: 1240491
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hyperlipemia in nephrotic syndrome].
    GUARINI G
    Arch Maragliano Patol Clin; 1957 Dec; 13(6):1673-707. PubMed ID: 13535006
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipid factors in the hypertension syndrome.
    Giles TD
    J Cardiovasc Risk; 1997 Aug; 4(4):257-9. PubMed ID: 9477202
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lipid and lipoprotein studies in nephrotic syndrome cases in childhood].
    László A; Havass Z; Joó I; Bodrogi T; Turi S
    Kinderarztl Prax; 1985 Apr; 53(4):199-203. PubMed ID: 4010160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.